Cargando…
Power in Numbers: Harnessing Combinatorial and Integrated Screens to Advance Nanomedicine
[Image: see text] Nanocarriers have significant potential to advance personalized medicine through targeted drug delivery. However, to date, efforts to improve nanoparticle accumulation at target disease sites have largely failed to translate clinically, stemming from an incomplete understanding of...
Autores principales: | Boehnke, Natalie, Hammond, Paula T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791056/ https://www.ncbi.nlm.nih.gov/pubmed/35098219 http://dx.doi.org/10.1021/jacsau.1c00313 |
Ejemplares similares
-
Harnessing RNAi nanomedicine for precision therapy
por: Peer, Dan
Publicado: (2014) -
Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment
por: Sun, Bo, et al.
Publicado: (2020) -
Harnessing Protein Corona for Biomimetic Nanomedicine Design
por: Chen, Zhidong, et al.
Publicado: (2022) -
Combinatorial synthesis and screening of cancer cell-specific nanomedicines targeted via phage fusion proteins
por: Gillespie, James W., et al.
Publicado: (2015) -
Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases
por: Carney, Christine P., et al.
Publicado: (2021)